Fenley, J.d.C.; de Barros, P.P.; Carmo, P.H.F.d.; Garcia, M.T.; Rossoni, R.D.; Junqueira, J.C.
Repurposing HIV Protease Inhibitors Atazanavir and Darunavir as Antifungal Treatments against Candida albicans Infections: An In Vitro and In Vivo Study. Curr. Issues Mol. Biol. 2022, 44, 5379-5389.
https://doi.org/10.3390/cimb44110364
AMA Style
Fenley JdC, de Barros PP, Carmo PHFd, Garcia MT, Rossoni RD, Junqueira JC.
Repurposing HIV Protease Inhibitors Atazanavir and Darunavir as Antifungal Treatments against Candida albicans Infections: An In Vitro and In Vivo Study. Current Issues in Molecular Biology. 2022; 44(11):5379-5389.
https://doi.org/10.3390/cimb44110364
Chicago/Turabian Style
Fenley, Juliana de C., PatrÃcia P. de Barros, Paulo H. F. do Carmo, MaÃra T. Garcia, Rodnei D. Rossoni, and Juliana C. Junqueira.
2022. "Repurposing HIV Protease Inhibitors Atazanavir and Darunavir as Antifungal Treatments against Candida albicans Infections: An In Vitro and In Vivo Study" Current Issues in Molecular Biology 44, no. 11: 5379-5389.
https://doi.org/10.3390/cimb44110364
APA Style
Fenley, J. d. C., de Barros, P. P., Carmo, P. H. F. d., Garcia, M. T., Rossoni, R. D., & Junqueira, J. C.
(2022). Repurposing HIV Protease Inhibitors Atazanavir and Darunavir as Antifungal Treatments against Candida albicans Infections: An In Vitro and In Vivo Study. Current Issues in Molecular Biology, 44(11), 5379-5389.
https://doi.org/10.3390/cimb44110364
